Black, Chelsea M <br/><br/>
Apoptosis-regulated low-avidity cancer-specific CD8(+) T cells can be rescued to eliminate HER2/neu-expressing tumors by costimulatory agonists in tolerized mice.  [electronic resource] 

 -  Cancer immunology research  Apr 2014 
 - 307-19 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>2326-6074 
<br/><br/><label>Standard No.: </label>10.1158/2326-6066.CIR-13-0145  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antigens, Differentiation--pharmacology<br/>Antigens, Neoplasm--immunology<br/>Apoptosis--immunology<br/>CD24 Antigen--genetics<br/>CD4-Positive T-Lymphocytes--immunology<br/>CD8-Positive T-Lymphocytes--drug effects<br/>Cell Line, Tumor<br/>Disease Models, Animal<br/>Fas Ligand Protein--genetics<br/>Female<br/>Humans<br/>Immunodominant Epitopes--immunology<br/>Interferon-gamma--biosynthesis<br/>Mice<br/>Mice, Transgenic<br/>Neoplasms--drug therapy<br/>Receptor, ErbB-2--chemistry<br/>Receptors, TNF-Related Apoptosis-Inducing Ligand--genetics<br/>T-Cell Antigen Receptor Specificity--immunology<br/>Tumor Escape--immunology